EFM
PTCT icon

E Fund Management’s PTC Therapeutics PTCT Stock Holding History

E Fund Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Sell
5,616
-3,247
-37% -$234K 0.01% 293
2026
Q1 		$604K Buy
+8,863
New +$628K 0.02% 245
2025
Q2 		$532K Buy
10,898
+5,564
+104% +$264K 0.03% 220
2025
Q1 		$272K Sell
5,334
-186
-3% -$9.28K 0.01% 328
2024
Q4 		$249K Sell
5,520
-986
-15% -$42.2K 0.01% 339
2024
Q3 		$241K Buy
+6,506
New +$218K 0.01% 286
2024
Q2 		– Sell
-13,908
Closed -$405K – 359
2024
Q1 		$405K Sell
13,908
-4,280
-24% -$120K 0.03% 216
2023
Q4 		$501K Buy
18,188
+7,589
+72% +$174K 0.03% 164
2023
Q3 		$238K Buy
10,599
+212
+2% +$7.88K 0.02% 230
2023
Q2 		$422K Buy
10,387
+1,655
+19% +$81K 0.03% 155
2023
Q1 		$423K Sell
8,732
-2,351
-21% -$107K 0.03% 148
2022
Q4 		$423K Buy
11,083
+2,202
+25% +$91.5K 0.04% 170
2022
Q3 		$446K Sell
8,881
-4,672
-34% -$229K 0.04% 147
2022
Q2 		$543K Buy
13,553
+5,723
+73% +$201K 0.05% 131
2022
Q1 		$292K Buy
+7,830
New +$302K 0.01% 202

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

E Fund Management's PTCT Position: Q2 2026 in Review

E Fund Management reduced its PTC Therapeutics (PTCT) stake by 37% in Q2 2026, selling an estimated $234K and leaving 5,616 shares worth $458K. The position accounts for 0.01% of the portfolio, ranked #293.

E Fund Management first reported a position in PTCT in Q1 2022 and has held it in 15 quarters since. The position peaked at $604K in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • E Fund Management held 5,616 shares of PTC Therapeutics worth $458K as of Q2 2026.
  • E Fund Management sold 3,247 PTC Therapeutics shares in Q2 2026, an estimated $234K.
  • PTC Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #293 holding.
  • E Fund Management first reported a position in PTC Therapeutics in Q1 2022 and has held it in 15 quarters since.
  • E Fund Management's PTC Therapeutics position peaked at $604K in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.